|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| OPERATING ACTIVITIES | |||||
| Net income attributable to Tompkins Financial Corporation | |||||
| Adjustments to reconcile net income to cash provided by (used in) operating activities: | |||||
| Provision for credit loss expense | |||||
| Depreciation and amortization of premises, equipment, and software | |||||
| Amortization of intangible assets | |||||
| Gain on sale of TIA | |||||
| Transaction costs related to the sale of TIA | |||||
| Earnings from corporate owned life insurance | |||||
| Net amortization on securities | |||||
| Amortization/accretion related to purchase accounting | |||||
| Current year tax liability | |||||
| Deferred income tax (benefit) expense | |||||
| Net (gain) loss on securities transactions | |||||
| Penalties on prepayment of FHLB borrowings | |||||
| Net gain on sale of loans originated for sale | |||||
| Proceeds from sale of loans originated for sale | |||||
| Loss on redemption of trust preferred debentures | |||||
| Loans originated for sale | |||||
| Loans held for sale | |||||
| Net gain on sale of bank premises and equipment | |||||
| Net excess tax (expense) benefit from stock based compensation | |||||
| Stock-based compensation expense | |||||
| Increase in accrued interest receivable | |||||
| Increase in accrued interest payable | |||||
| Other, net | |||||
| Net Cash Provided by Operating Activities | |||||
| INVESTING ACTIVITIES | |||||
| Proceeds from maturities, calls and principal paydowns of available-for-sale debt securities | |||||
| Proceeds from sales of available-for-sale debt securities | |||||
| Purchases of available-for-sale debt securities | |||||
| Purchases of held-to-maturity debt securities | |||||
| Proceeds from sale of VISA Class B shares | |||||
| Net increase in loans | |||||
| Proceeds from sale/redemptions of Federal Home Loan Bank stock | |||||
| Purchases of Federal Home Loan Bank and other stock | |||||
| Proceeds from sale of bank premises and equipment | |||||
| Purchases of bank premises, equipment and software | |||||
| Purchase of corporate owned life insurance | |||||
| Proceeds from redemption of corporate owned life insurance | |||||
| Proceeds from sale of other real estate owned | |||||
| Net proceeds from the sale of TIA | |||||
| Other, net | |||||
| Net Cash (Used in) Provided by Investing Activities | |||||
| FINANCING ACTIVITIES | |||||
| Net increase (decrease) in demand, money market, and savings deposits | |||||
| Net increase in time deposits | |||||
| Net increase (decrease) in Federal funds purchased and securities sold under agreements to repurchase | |||||
| Increase in other borrowings | |||||
| Repayment of other borrowings | |||||
| Redemption of trust preferred debentures | |||||
| Cash dividends | |||||
| Common stock issued | |||||
| Repurchase of common stock | |||||
| Shares issued for dividend reinvestment plan | |||||
| Shares issued for employee stock ownership plan | |||||
| Net shares issued related to restricted stock awards | |||||
| Net proceeds from exercise of stock options | |||||
| Net Cash Provided by (Used in) Financing Activities | |||||
| Net Increase in Cash and Cash Equivalents | |||||
| Cash and cash equivalents, beginning of the period | |||||
| Total Cash and Cash Equivalents at End of Period | |||||
| Supplemental Cash Flow Information | |||||
| Cash paid during the year for - Interest | |||||
| Cash paid during the year for - Taxes | |||||
| Transfer of loans to other real estate owned | |||||
| Transfer of loans to other assets | |||||
| Right-of-use assets obtained in exchange for new lease liabilities | |||||
Loading...